aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2025. All rights reserved.
44 Tehama St, San Francisco, CA 94105
Privacy Policy
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
Santen Ventures, based in Emeryville, California, is a wholly-owned subsidiary of Santen Holdings. The company is dedicated to investing in promising seed-stage firms that are developing innovative technologies, particularly in the field of eye care and pharmaceuticals. Their core mission is to advance eye health and vision by supporting groundbreaking innovations that can lead to new treatments and therapies. Santen Ventures focuses on identifying and nurturing early-stage companies that have the potential to make significant contributions to the healthcare market.
Notable affiliated individuals include executives from Santen Holdings, who bring extensive experience in the pharmaceutical industry. Key investors are primarily from Santen Holdings, ensuring strong financial backing and strategic guidance. Among their achievements, Santen Ventures has successfully identified and invested in several pioneering startups that have gone on to develop impactful eye care solutions. The overall impact of Santen Ventures is seen in their contribution to advancing medical technology and improving patient outcomes in the field of ophthalmology.
Operating Status
Active
Ownership Type(s)
Venture Capital
Main Product(s)
Pharmaceuticals
Technology
Biotech
Tags
SaaS
Model Types
Recurring
Revenue Type(s)
Enterprise
Customer Type(s)
Americas
When was Santen Ventures founded?
Santen Ventures was founded in 2017.
Where is Santen Ventures’s headquarters located?
Santen Ventures’s headquarters is located in Emeryville, CA, US.
How many employees does Santen Ventures have?
Santen Ventures has 3805 employees as of Feb 6, 2024.
How much has Santen Ventures raised to-date?
As of July 05, 2023, Santen Ventures has raised a total of $59M (USD) since Sep 1, 2011.
Add Comparison
Total Raised to Date
$59M
USD
Last Update Sep 1, 2011
Total Employees Over Time
3805
As of Feb 2024
Santen Ventures Address
6401 Hollis St
suite 125
Emeryville,
California
94608
United States
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts